Who owns NEUROSENSE THERAPEUTICS LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neurosense Therapeutics stock

Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Clear Street 66k $10k 11% Sep 2024
 View chart
Citadel Advisors 25k $3.8k -14% Sep 2024
 View chart
Warberg Asset Management 20k $3.4k -37% Sep 2024
 View chart
UBS Group 200.00 $28.000000 -67% Sep 2024
 View chart